PAEDIATRICS

Growth in Childhood Development

  • Fundamental Task: Growth is a fundamental aspect of childhood development.
  • Key Interactions: Adequate skeletal lengthening depends on a complex interaction of genetic, hormonal, nutritional, and psychosocial variables.
  • Health Professional Role: Ensuring children reach their maximum height potential is a crucial responsibility for healthcare providers.
  • Parental Concerns: Addressing parental expectations and anxieties is important when managing concerns about a child’s height.

Normal Growth Patterns

  • Greatest Growth Velocity: Occurs in late fetal life.
  • Decreasing Velocity: Growth velocity decreases after birth until adolescence, with the notable exception of the pubertal growth spurt.
  • Gender Differences: Growth rates are similar between genders until puberty.
  • Pubertal Growth Spurt: Occurs later and with higher velocity in males, resulting in average heights of 177 cm for males and 164 cm for females.

Identifying Growth Disorders

  • Key Distinction: Differentiate between a child who is short but growing well and one who is growing poorly.
  • Short Stature Definition: Defined as height below the 1st centile for age on growth charts.
  • Dynamic Process: Growth is dynamic and requires multiple height measurements over at least 6 months.
  • Normal vs. Pathologic Growth: Normal growth is parallel to the centiles; deviations may indicate pathological causes of growth failure.

Assessing Growth

  • Measurements:
    • Height: Plot against standard centile charts.
    • Weight: Plot against standard centile charts.
    • Body Proportions: Assess body proportions.
    • Growth Velocity: Plot against growth velocity centile charts.
  • Consistency in Measurement:
    • Ideally, one person should measure the patient at every visit to avoid inter-observer bias.
  • Measurement Techniques:
    • Children <2 Years:
      • Place on a supine table.
      • One measurer holds the child’s head.
      • Another performs the measurement.
    • Children ≥2 Years:
      • Use a stadiometer.
      • Child stands without shoes or socks.
      • Heels and back against the wall/board.
      • Head straight.
      • Gentle upward pressure applied to the mastoid process.
  • Normal Body Proportions:
    • Arm Span to Total Height Ratio: Around 1.0 at all ages.
    • Upper Segment to Lower Segment Ratio:
      • Approximately 1.7 as a neonate.
      • Decreases to 1.4 at age 4-5 years.
      • Just below 1.0 by age 10-12 years.
  • Growth Velocity Assessment:
    • Serial measurements are required, preferably over 1 year.
    • Calculate growth over time (convert to cm/year).
    • Growth velocity is a sensitive marker for growth slowing, even if not apparent on standard centile charts.
    • Repeated height values plotted on a standard chart usually give a good indication of current growth velocity.

Predicting Adult Height

  • Parental Heights: Mother’s and father’s heights are needed.
  • Female Child:
    • Subtract 13 cm from the father’s height.
    • Plot the adjusted paternal height on the female chart.
    • Plot the mother’s height on the female chart.
    • The midpoint between these two values is the mid parental height (MPH).
  • Male Child:
    • Add 13 cm to the mother’s height.
    • Plot the adjusted maternal height on the male chart.
    • Plot the father’s height on the male chart.
    • The midpoint between these two values is the MPH.
  • Range for Prediction: The 3rd and 97th centiles for the child are 10 cm to either side of the MPH.
  • Bone Age Assessment:
    • Perform an X-ray of the wrist and hand.
    • Determine bone age, chronological age, and current height.
    • Use the Bayley-Pinneau tables to predict the likely adult height.

Interpreting Growth Data – Normal Variants

  • Assessment Goal: Determine if short stature is a normal variant or due to a pathological condition.
  • Normal Variants:
    • Familial Short Stature: Short parents likely to have short children growing at a normal rate.
    • Constitutional/Maturational Delay:
      • Transient slowing of growth around 3 years and 11-12 years of age.
      • May have a family history of delayed growth and pubertal development.
      • Bone age, height age, and growth velocity help distinguish from familial short stature.
  • Bone Age: Delayed bone age reflects physiologically delayed growth.
  • Growth Chart: Use corrected growth charts for bone age to assess growth patterns.
  • Outcome:
    • Patients with familial short stature are likely to remain short adults.
    • Children with constitutional delay are likely to achieve a good height outcome as their growth catches up over time.

Interpreting Growth Data

  • Normal Variants vs. Pathology:
    • Familial Short Stature: Children grow at a normal rate but are shorter due to familial patterns; these children will be short adults.
    • Constitutional Delay: Children experience a temporary slowing of growth around ages 3 and 11-12, often with a family history of delayed growth and pubertal development. They typically catch up in height later.

Pathological Causes of Short Stature

  • Indicators of Pathology:
    • History and Examination:
      • Include birth weight
      • symptoms of chronic illness
      • psychosocial issues
      • physical examination for dysmorphic features.
    • Height Velocity: Falling off centiles is a key indicator of pathology.
    • Weight Changes: Weight falling off the centiles can indicate chronic illness, nutritional, or psychosocial causes.
  • Female Patients: All females with short stature (<1st centile) should have a karyotype to exclude Turner syndrome.
  • Mnemonic ‘Endocrine PICNICS’: Used to remember pathological conditions causing short stature:
    • Endocrine: Growth hormone deficiency, hypothyroidism, Cushing’s syndrome.
    • Psychosocial: Emotional deprivation.
    • Intrauterine: Intrauterine growth restriction.
    • Chronic diseases: Chronic renal insufficiency, gastrointestinal diseases, cardiac diseases.
    • Nutritional: Malnutrition, specific nutrient deficiencies.
    • Iatrogenic: Effects of certain medications like corticosteroids.
    • Congenital syndromes: Genetic syndromes like Turner syndrome, Down syndrome.
    • Skeletal dysplasias: Conditions like achondroplasia.

Treatment of Short Stature

  • Nonpathological Causes: Explanation and reassurance are crucial for both parents and child.
  • Boys with Constitutional Delay: May benefit from testosterone administration to induce puberty.
  • Catch-up Growth: Possible in some conditions once underlying issues are controlled, although may not reach premorbid height potential.
  • Referral: To a pediatric endocrinologist if a pathological cause is suspected.

Tall Stature

  • Less Common: Tall stature is less commonly a presenting problem.
  • Familial Tall Stature: Often familial, with serial measurements and parents’ heights used for assessment.
  • Endocrine and Syndromal Causes: Include hyperthyroidism, precocious puberty, growth hormone-secreting tumors, and syndromes like Klinefelter and Marfan syndrome.
  • Treatment: Usually reassurance; in rare cases, sex steroid administration may be used to reduce final height.

Conclusion

  • Accurate Assessment: Careful history, examination, and growth parameter assessment are essential.
  • Reassurance: Vital for non-pathological cases.
  • Referral: Required for complex or pathological cases.
  • Support: Medical and social support are crucial for managing growth disorders.

Additional Notes:

  • Constitutional Growth Delay: Transient slowing of growth at approximately 3 years and again at 11-12 years of age; may have a family history of delayed growth and pubertal development. Bone age, height age, and growth velocity can help distinguish this from familial short stature.
  • Growth Hormone Therapy: Considered for children who meet specific criteria; applications are made to a central governing body.
  • Tall Stature Syndromes: Klinefelter syndrome (47XXY), Marfan syndrome (autosomal dominant, fibrillin defect), Sotos syndrome (cerebral gigantism), Homocystinuria (autosomal recessive, similar to Marfan but with poor bone density and thrombosis tendency), Beckwith-Wiedemann syndrome (fetal overgrowth, risk of malignancy).

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.